Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Fragment-sized thiazoles in fragment-based drug discovery campaigns : friend or foe?
ID
Proj, Matic
(
Author
),
ID
Hrast, Martina
(
Author
),
ID
Knez, Damijan
(
Author
),
ID
Bozovičar, Krištof
(
Author
),
ID
Grabrijan, Katarina
(
Author
),
ID
Meden, Anže
(
Author
),
ID
Gobec, Stanislav
(
Author
),
ID
Frlan, Rok
(
Author
)
PDF - Presentation file,
Download
(2,30 MB)
MD5: E86DBB9F5C097394033A065F612F3404
URL - Source URL, Visit
https://pubs.acs.org/doi/10.1021/acsmedchemlett.2c00429
Image galllery
Abstract
Thiazoles exhibit a wide range of biological activities and therefore represent useful and attractive building blocks. To evaluate their usefulness and pinpoint their liabilities in fragment screening campaigns, we assembled a focused library of 49 fragment-sized thiazoles and thiadiazoles with various substituents, namely amines, bromides, carboxylic acids, and nitriles. The library was profiled in a cascade of biochemical inhibition assays, redox activity, thiol reactivity, and stability assays. Our study indicates that when thiazole derivatives are identified as screening hits, their reactivity should be carefully addressed and correlated with specific on-target engagement. Importantly, nonspecific inhibition should be excluded using experimental approaches and in silico predictions. To help with validation of hits identified in fragment screening campaigns, we can apply our high-throughput profiling workflow to focus on the most tractable compounds with a clear mechanism of action.
Language:
English
Keywords:
thiazoles
,
hit profiling
,
promiscuous compounds
,
frequent hitters
,
privileged scaffolds
,
fragments
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
FFA - Faculty of Pharmacy
Publication status:
Published
Publication version:
Version of Record
Year:
2022
Number of pages:
Str. 1905–1910
Numbering:
Vol. 13, iss. 12
PID:
20.500.12556/RUL-143239
UDC:
547.78:615.4:54
ISSN on article:
1948-5875
DOI:
10.1021/acsmedchemlett.2c00429
COBISS.SI-ID:
130706947
Publication date in RUL:
09.12.2022
Views:
694
Downloads:
136
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
ACS medicinal chemistry letters
Publisher:
American Chemical Society
ISSN:
1948-5875
COBISS.SI-ID:
2959217
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Secondary language
Language:
Slovenian
Keywords:
hit profiliranje
,
promiskuitetne spojine
,
pogosti napadalci
,
privilegirani odri
,
fragmenti
,
tiazoli
,
farmacevtska kemija
Projects
Funder:
ARRS - Slovenian Research Agency
Project number:
P1-0208
Name:
Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin
Funder:
ARRS - Slovenian Research Agency
Project number:
J1-2484
Name:
Razvoj protibakterijskih učinkovin z delovanjem na validirane tarče v biosintezi peptidoglikana
Funder:
ARRS - Slovenian Research Agency
Funding programme:
Young researchers
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back